Fairvalue-Calculator Fairvalue-Calculator
EN DE

Milae Bioresources Co (218150) Fair Value & Analysis

Consumer Defensive · KR · Market cap 38.6B KRW

Price1,726 KRW
Fair Value2,479 KRW
Upside+43.6%
Quality89/100
Evidence: Medium Range 1,689 KRW – 3,268 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Milae Bioresources Co (218150) currently trades at 1,726 KRW, while our model-based Fair Value estimate is 2,479 KRW — implying the stock looks roughly 43.6% undervalued today. We read business quality at 89/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Milae Bioresources Co., Ltd. provides feed additives in Korea. It also offers processed feed, feed preservatives, and feed ingredients. In addition, the company offers minerals and other specialty feed additives. The company was founded in 1998 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Archer-Daniels-Midland Company (ADM) -57% MHP SE (MHPC) -88% Muyuan Foods Group (002714) +75% Bunge Global SA (BG) +6% Tyson Foods, Inc (TSN) -41% Wens Foodstuff Group (300498) -3%

Frequently asked questions

Is Milae Bioresources Co (218150) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,479 KRW versus a price of 1,726 KRW — about +44% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 218150?
Our 21-model fair value for Milae Bioresources Co is 2,479 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 1,726 KRW.
What is the quality score of 218150?
Milae Bioresources Co has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.